Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hideaki Nakajima

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Nature cancer

Annals of the rheumatic diseases

The Journal of experimental medicine

Stem cells (Dayton, Ohio)

Yokohama City University Graduate School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yokohama City University Graduate School of Medicine

Japan

Professor and Chairman :: Department of Stem Cell and Immune Regulation

Publications

Shunsuke Soma, Koichi Murakami, Yumi Fukuchi, Hiroyoshi Kunimoto, Hideaki Nakajima
OGT ensures survival of mouse fetal liver hematopoietic progenitors partly by regulating Bcl-xL and oxidative phosphorylation. Stem cells (Dayton, Ohio) (2023)
Shunsuke Uno, Hiroyuki Gatanaga, Tsunefusa Hayashida, Mayumi Imahashi, Rumi Minami, Michiko Koga, Sei Samukawa, Dai Watanabe, Teruhisa Fujii, Masao Tateyama, Hideta Nakamura, Shuzo Matsushita, Yusuke Yoshino, Tomoyuki Endo, Masahide Horiba, Toshibumi Taniguchi, Hiroshi Moro, Hidetoshi Igari, Shigeru Yoshida, Takanori Teshima, Hideaki Nakajima, Masako Nishizawa, Yoshiyuki Yokomaku, Yasumasa Iwatani, Atsuko Hachiya, Shingo Kato, Naoki Hasegawa, Kazuhisa Yoshimura, Wataru Sugiura, Tadashi Kikuchi
Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study. The Journal of antimicrobial chemotherapy (2023)
Katherine Knorr, Jahan Rahman, Caroline Erickson, Eric Wang, Mara Monetti, Zhuoning Li, Juliana Ortiz-Pacheco, Andrew Jones, Sydney X Lu, Robert F Stanley, Maria Baez, Nina Fox, Cynthia Castro, Alessandra E Marino, Caroline Jiang, Alexander V Penson, Simon J Hogg, Xiaoli Mi, Hideaki Nakajima, Hiroyoshi Kunimoto, Koutarou Nishimura, Daichi Inoue, Benjamin D Greenbaum, David Knorr, Jeffrey V Ravetch, Omar Abdel-Wahab
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia. Nature cancer (2023)
Haruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, Satoshi Koyama, Hiroyuki Takahashi, Yuki Nakajima, Hiroyoshi Kunimoto, Takayoshi Tachibana, Takuya Miyazaki, Kenji Matsumoto, Masatsugu Tanaka, Etsuko Yamazaki, Shin Fujisawa, Heiwa Kanamori, Masataka Taguri, Hideaki Nakajima
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantation. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Takuma Ohashi, Jun Aoki, Taiki Ando, Yasufumi Ishiyama, Yoshimi Ishii, Kazuho Miyashita, Yuki Nakajima, Takayoshi Tachibana, Maki Hagihara, Kenji Matsumoto, Masatsugu Tanaka, Heiwa Kanamori, Shin Fujisawa, Hideaki Nakajima, null null
Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. Bone marrow transplantation 57 (7) (2022)
Naomi Tsuchida, Yosuke Kunishita, Yuri Uchiyama, Yohei Kirino, Makiko Enaka, Yukie Yamaguchi, Masataka Taguri, Shoji Yamanaka, Kaoru Takase-Minegishi, Ryusuke Yoshimi, Satoshi Fujii, Hideaki Nakajima, Naomichi Matsumoto
Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Annals of the rheumatic diseases (2021)
Asuka Ogai, Ryuto Yoshida, Chiaki Yuasa, Kenko Chin, Katsumichi Fujimaki, Hideaki Nakajima
Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual. International journal of hematology (2021)
Nouraiz Ahmed, Martin Etzrodt, Philip Dettinger, Tobias Kull, Dirk Loeffler, Philipp S Hoppe, James S Chavez, Yang Zhang, Germán Camargo Ortega, Oliver Hilsenbeck, Hideaki Nakajima, Eric M Pietras, Timm Schroeder
Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation. The Journal of experimental medicine 219 (1) (2021)
Hiroyoshi Kunimoto, Hideaki Nakajima
TET2: A cornerstone in normal and malignant hematopoiesis. Cancer science 112 (1) (2020)

Hideaki Nakajima.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hideaki Nakajima